Date
NH Formulary Status: Restricted
Indication: Restricted to treatment of adults with:
- Confirmed MRSA skin and soft tissue infections; AND
- Oral anti-MRSA agents are not an option; AND
- Outpatient use OR inpatient use if dalbavancin allows earlier hospital discharge; AND
- Intended treatment duration is 1 week or more; AND
- Patient is unable to receive IV vancomycin or daptomycin due to logistical barriers.
Dalbavancin injectable information for NH prescribers. Dalbavancin information also available on Firstline.